Guilin Rhine Biotechnology Co., Ltd. was established in November 2000. It is a technological and export-oriented private enterprise specializing in the research and development, production and sales of natural health products. The company has nearly 20 years of experience in the plant extraction industry. It is a leader in the global plant extraction industry and the first listed company in the domestic plant extraction industry. The company is committed to building the world's leading natural health product platform to improve people's health and make life better! The company invested more than 500 million yuan to build a new fourth-generation natural extract production base that was put into operation in 2017. It covers an area of ​​about 300 acres. It has advanced production equipment and an automated intelligent extraction production line that meets GMP standards. The annual raw material processing capacity is up to More than 60,000 tons. At the same time, three marketing centers in Shanghai, Los Angeles, and Savona, Italy have been established for sales. The company has passed GMP, HACCP, ISO and other certifications, and many products have KOSHER, HALAL, ORGANIC, SC, FSSC22000 and other certificates. Among them, mogroside and stevioside both passed the GRAS certification of the U.S. FDA in 2011, making it the first company in the world to obtain both product certifications at the same time. The company's products are widely used in food and beverage, health care products, cosmetics, pharmaceuticals and other industries, and are exported to more than 60 countries and regions around the world such as the United States, Europe, South Korea, and Japan. As a pioneer in the plant extraction industry, the company has strong technical research and development capabilities. The company's technology center is recognized as the Guangxi autonomous region-level enterprise technology center, and has research and development platforms such as post-doctoral research workstations, Guangxi academician workstations, Guangxi autonomous region-level engineering technology centers, and Luo Han Guo Engineering Research Institute. As of June 2018, the company has 50 national invention patents and has mastered more than 300 core technologies for the extraction of natural ingredients. In 2017, the company established two new R&D platforms, the Plant Science Innovation Center and the Shanghai Health Product R&D Center, and formed an agricultural technology R&D team led by returnees to provide strong technical support for the innovation and development of the company's business. Looking forward to the future, the company will adhere to the business philosophy of "green technology, healthy future", closely focus on the vision of building a world-leading natural health product platform, continue to increase investment or mergers and acquisitions in upstream and downstream related businesses, and focus on the development and development of raw material bases. Build and build a brand and channel operation platform for downstream industries such as functional food and beverages, dietary supplements, cosmetics, and pharmaceuticals, form an ecological closed loop of the entire industry chain, and build the company into a new type of healthy consumer goods company, in order to realize the "Healthy China 2030" action Plan to make due contribution!

Registered Capital:  56,5.215 million

Registered Address:  No. 19, Renmin South Road, Lingui District, Guilin

Company Type:  Production

Business Scope:  The research and development, production, sales, technology transfer and self-support import and export of plant extracts, Chinese medicine extracts, food and food additives, feed and feed additives, plant extract formula products, skin care cosmetics and personal care products (the above items involve administrative Except for licensing projects); plant seedling cultivation and breeding research, application, promotion and technology transfer